medigraphic.com
ISSN 0035-0052 (Impreso)

2003, Número 2

<< Anterior Siguiente >>

Rev Mex Pediatr 2003; 70 (2)


Leucocitosis y trombocitosis en un caso probable de tos ferina

Chacón GM, Flores NG, Hernández DL, Lavalle VA

Idioma: Español
Referencias bibliográficas: 18
Paginas: 77-80
Archivo PDF: 45.64 Kb.


RESUMEN

Se presenta el caso de un lactante con probable tos ferina que durante su evolución presentó hiperleucocitosis, trombocitosis, neumonía, insuficiencia respiratoria aguda, edema agudo pulmonar, insuficiencia renal, choque cardiogénico y defunción. Se hace una revisión sobre tos ferina y su pronóstico, cuando se acompaña de hiperleucocitosis.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Hampl SE, Jackson MA. Pertussis. Pediatrics in Review 2000; 21: 11-7.

  2. Kumate J, Gutiérrez G, Muñoz HO, Santos PJI. Manual de Infectología Clínica. 16o ed. México: Méndez Editores; 2001. p. 103-9.

  3. McCarthy VP. Hyperleukocytosis with pertussis. J Assoc Acad Minor Phys 1997; 8: 52-4.

  4. Pierce C, Klein N, Peters M. Is leukocytosis a predictor of mortality in severe pertussis infection? Intensive Care Med 2000; 26: 1512-4.

  5. Tam TWS. Bentsi-Enchill A. The retum of the 100-day cough: resurgence of pertussis in 1990’s. CMAJ 1998; 159: 695-6.

  6. Reporte Epidemiológico. Secretaría de Salud, México, 2002; 219: 3.

  7. Crowcroft NS, Britto J. Whooping cough-a continuing problem. BMJ 2002; 324: 1537-8.

  8. Ranganathan S, Tasker R, Booy R, Habibi P, Nadel J, Britto J. Pertussis is increasing in unimmunized infants: is a change in policy needed? Arch Dis Child 1999; 80: 297-9.

  9. De Melker HE, Verstegh FGA, Conyn-van Spaendonck MAE, Elvers LHG, Berbers GAM, Van der Zee A et al. Specificity and sensitivity of high levels of immunoglobullin G antibodies against pertussis toxina in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol 2000; 38: 800-6.

  10. Grimpell E, Njampeko E, Begué P, Guiso N. Rapid diagnosis of pertussis in young infants and mother’s serology. Clin Diag Lab Immunol 1997; 4: 723-6.

  11. Heininger U, Klich K, Stehr K, Cherry JD. Clinical findings in Bordetella pertussis infections: Results of a prospective multicenter surveillance study. Pediatrics 1997; 100: e10.

  12. Yaari E, Yafe-Zimerman Y, Schwartz SB, Slater PE, Shvartzman P, Andoren N et al. Clinical manifestations of Bordetella pertussis infection in immunized children and young adults. Chest 1999; 115: 1254-8.

  13. Halperin SA, Bortlussi R, Langley JM, Miller B, Estwood BJ. Seven days of erythromycin isolate is as effective as fourteen days for the treatment of Bordetella pertussis infection. Pediatrics 1997; 100: 65-71.

  14. Tsan TWS, Cao X, White JE, Sacco J, Lee Y. Pertussis toxin induced lung edema. Am J Respir Cell Mol Biol 1999; 20: 465-73.

  15. Athens JW. Variations of leukocytes in disease. In: Lee GR, Bithell TC, Foester J, Athens JW, editors. Wintrobe’s Clinical Hematology. 10th ed. USA: Lippincott Williams & Wilkins; 1999. p. 1852-4.

  16. Tobler A. Hematological emergencies. Schweiz Rundsch Med Prax 1997; 86: 302-7.

  17. Crowcroft NS, Andrews N, Rooneyl C, Brisson M, Miller E. Deaths from pertussis are underestimated in England. Arch Dis Child 2002; 86: 336-8.

  18. Wortis N, Strebel PM, Wharton M, Bardenheimer B, Hardy IRB. Pertussis deaths: report of 23 cases in the United States, 1992 and 1993. Pediatrics 1996; 97: 607-12.




2020     |     www.medigraphic.com